A topical treatment blocking the enzyme LSD1 activated immune responses in skin cells and slowed tumor growth in models of ...
A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous squamous cell carcinoma (cSCC), one of the most common cancers in the world, ...
A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous ...
Explore how a topical cream targets squamous cell carcinoma by enhancing immune responses in the skin for tumour suppression.
A topical cream that activates the skin’s immune defenses may slow or prevent the growth of common skin cancers.
Researchers at the Institute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE) at Miguel Hernández University (UMH) have coordinated an international clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results